Atlas Trials

A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy

Clinical trial NCT01497652 · COMPLETED

Trial details

NCT number
NCT01497652
Sponsor
Georgetown University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2012-01-01
Primary completion
2015-03-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.